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Aneuploidy is prevalent in human oocytes and resulting
embryos and its incidence increases with maternal age.
Depending on the age of the female or the particulartive Healthcare Ltd. Published by Elsevier
.rbmo.2013.02.006circumstance of the couple, more than half of their embryos
are likely to be aneuploid (Fragouli and Wells, 2011). Avoid-
ing the selection of aneuploid embryos for transfer after IVF
is a clinical imperative. The only method available for
assessing embryo ploidy uses invasive and expensiveLtd. Open access under CC BY-NC-ND license.
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accurate full chromosome copy number of a biopsied blasto-
mere from the early embryo, trophoblast cells of the blasto-
cyst or the polar bodies of the oocyte and zygote. Various
robust and reliable technologies have been recently intro-
duced, such as array comparative genomic hybridization,
single-nucleotide polymorphism arrays or quantitative PCR,
which have confirmed the high incidence of aneuploidy in
human oocytes and embryos (Fragouli et al., 2006, 2010;
Kamiguchi et al., 1993; Munne et al., 1993). One of the main
causal factors of aneuploidy is believed to be premature
pre-division of chromatids and non-disjunction during meio-
sis, but several other contributory factors such as paternal
or mitotic aneuploidy have been implicated. Aneuploidy in
human embryos results in miscarriage, implantation failure
or the birth of an affected child. PGS provides couples at
high risk of embryo aneuploidy the opportunity for clinics
to selectively transfer a euploid embryo, if available.
Recently, it has been shown that the incidence of live birth
in young, good-prognosis women, with a theoretically low
risk of embryo aneuploidy is enhanced by PGS (Yang
et al., 2012). Furthermore, where there is the need to trans-
fer only a single or a maximum of two embryos, either by
regulation (such as in the UK) or good practice, the selection
of embryos from either euploid oocytes or embryos has
improved outcome in specific circumstances (Fishel et al.,
2010, 2011; Potter et al., 2012; Schoolcraft et al., 2012).
The development of commercially available time-lapse
devices for the IVF laboratory during recent years has
enabled embryologists to observe and study the develop-
ment of human embryos continuously and, therefore, more
precisely than was possible previously. Such monitoring of
the dynamics of embryo development, in addition to tradi-
tional qualitative morphological observations, often
referred to as morphokinetics, provides a plethora of infor-
mation on the development of individual embryos. These
data, generated by the manual or automatic recording or
annotation of images collected over precise time points,
can be retrospectively analysed against outcome variables,
such as blastulation, implantation, ploidy or live birth in an
attempt to identify prospective selection algorithms for
embryo transfer. Morphokinetic analyses promise to provide
IVF practitioners with novel markers of embryo viability.
Recent studies (Dal Canto et al., 2012; Meseguer et al.,
2011, 2012; Pribensky et al., 2010; Wong et al., 2010) have
discussed the potential value of morphokinetic variables
measured by time-lapse monitoring for improved embryo
selection.
The application of time-lapse embryo monitoring in a
clinical IVF setting avoids the need to remove embryos from
incubation conditions to make a daily observation. It allows
embryologists to rewind or freeze images in order to con-
sider the detail and context of embryo development with
practical flexibility. The EmbryoScope is the first instrument
to provide a safe, stable incubation environment (with low
incubation volume and direct heat transfer) combined with
internal microscopy. Meseguer et al. (2012) observed a 20%
increase in pregnancy rate compared with standard incuba-
tion and attributed this improvement to the EmbryoScope’s
stable culture conditions and use of morphokinetic variablesfor embryo selection. This study centre’s experience is sim-
ilar and this was the reason for the EmbryoScope being
selected for this study.
As both ploidy analysis from PGS and morphokinetic vari-
ables from time-lapse imaging are two techniques that,
individually, have been demonstrated to have the potential
to significantly improve the incidence of clinical pregnancy
compared with traditional culture and selection methods,
this study examined whether euploid or aneuploid embryos
display differing morphokinetic variables over the preim-
plantation cleavage period. Using trophectoderm biopsy
subsequent to controlled culture conditions, the objective
of this study was to determine whether embryos with a sin-
gle or multiple aneuploidy displayed temporal morphokinet-
ic variables that were significantly different from euploid
embryos. If any variants were established, a further objec-
tive was to develop a model to categorize the risk of aneu-
ploidy in embryos based on this non-invasive morphokinetic
data.
Materials and methods
Data obtained for this research were obtained from the
treatment of 25 couples attending an independent IVF clinic
(CARE Fertility, Manchester, United Kingdom) from May
2011 to July 2012. All protocols complied with UK regulation
(Human Fertilisation and Embryology Act, 1990, 2008). The
study did not require ethical or institutional review board
approval, having been performed according to previously
validated procedures. This was a retrospective cohort study
blinded to ploidy, with recording of embryo development
using time-lapse technology (EmbryoScope; Unisense Fertil-
itech, Denmark) and strict adherence to annotation proto-
cols for the variables defined in Table 1.
Criteria for patients for pre-genetic screening
The couples selected for this study requested or were rec-
ommended PGS due to a history of recurrent implantation
failure following IVF (defined as more than two failed IVF
attempts), recurrent miscarriage (defined as more than
two spontaneous miscarriages), severe male factor infertil-
ity, previous aneuploidy or advanced female age (defined as
>37 years). Female age ranged from 31 to 47 years
(mean ± standard deviation 38.6 ± 3.6 years).
Ovarian stimulation
Pituitary suppression and ovarian stimulation was per-
formed in 75% of patients with a gonadotrophin-releasing
hormone agonist (Suprecur; 0.5 ml subcutaneously daily;
Sanofi Aventis, UK) or antagonist for the remainder (Cetro-
tide; 0.25 mg daily; Merck Serono, UK). Ovarian stimulation
was achieved using human menopausal gonadotophin
(Menopur, Ferring, UK) and/or recombinant FSH (Gonal-F;
Merck Serono), with doses ranging from 150 to 600 IU per
day according to patient type and response. No differences
were observed in ploidy for the stimulation regimens or
doses (data not shown).
Table 1 Definition of variables used in the analysis.
Definition
Morphokinetic parameters and
multinucleation, annotated
daily up to the point of
trophectoderm biopsy
tPNfaded Time when both pronuclei had faded
tn Time from insemination to completion of division to n cells
tSC Time from insemination to when the first cells of the embryo began to join
together and compact (images could be rewound in order to establish the earliest
signs of compaction)
tM Time from insemination to formation of a morula, where all the cells had
undergone the compaction process and cell boundaries were unclear
tSB Time from insemination to start of blastulation, when the first signs of a cavity
were visible (images could be rewound in order to establish the earliest signs of
cavitation)
tB Time from insemination to formation of a full blastocyst; when the blastocoele
filled the embryo with <10% increase in its diameter
tEB Time from insemination to expanded blastocyst; when the blastocyst had
increased in diameter by more than 30% and the zona pellucida started to thin
tHB Time from insemination to hatching blastocyst, when trophectoderm herniation
through the zona pellucida was first observed
MN2 Multinuclearity at the 2-cell stage
MN4 Multinuclearity at the 4-cell stage
Variables of duration, calculated from the
morphokinetic parameters
cc2 Time of second cell cycle (t3–t2), from 2 to 3 cells
cc3 Time of third cell cycle (t5–t3), from 3 to 5 cells
s2 Time of synchrony of the second cell cycle (t4–t3), from 2 to 4 cells
s3 Time of synchrony of the third cell cycle (t8–t5), from 4 to 8 cells
Blastulation Time of blastulation, from start of blastulation to formation of a full blastocyst
(tB–tSB)
1ﬁ 3 Direct or rapid (<5 h) cleavage from 1 to 3 cells, referred to as irregular division
pattern
2ﬁ 5 Direct or rapid (<5 h) cleavage from 2 to 5 cells, referred to as irregular division
pattern
Modelling a risk classification of aneuploidy in human embryos 479Oocyte retrieval, denudation and ICSI
With the female patient under sedationwith a combination of
propofol (Braun, Germany), fentanyl (Auden McKenzie, UK)
and midazolam (Hamelyn, UK), transvaginal ultra-
sound-guided oocyte retrieval took place 36 h post human
chorionic gonadotrophin injection (10,000 IU; Pregnyl; Orga-
non,UK; orOvitrelle; Merck Serono) or agonist trigger, using a
dual lumen aspiration needle (Swemed; Vitrolife, UK)
connected to a vacuum pump (Rocket Medical, UK).
Oocyte–cumulus-complexes were recovered from follicular
aspirates using a stereomicroscope in a class II hood with a
heated stage, washed and cultured in Ferticult IVF medium
(Fertipro, Belgium) at 5% carbon dioxide in air, 37.0C, max-
imum humidity, for between 2 and 4 h before cumulus cell
denudation with 15–20 IU/ml cumulase (Origio, Denmark)
in the same medium and complete removal of the coronae
radiataewith a 140 lmpipette (EZ Squeeze; Research Instru-ments, UK). Oocytes at the metaphase-II stage underwent
insemination by intracytoplasmic sperm injection (ICSI).
Embryo culture and incubation
Following ICSI, oocytes were placed individually in micro-
wells of EmbryoSlides (Unisense Fertilitech) in 25 ll Global
IVF medium (LifeGlobal) supplemented with 10% dextran
serum supplement (Irvine Scientific) and were overlaid with
1.4 ml mineral oil (Fertipro, Belgium) in the EmbryoScope.
EmbryoSlides were prepared around the time of oocyte
recovery with medium and oil that had equilibrated
overnight.
Once loaded with the inseminated oocytes, EmbryoSlides
were placed into the EmbryoScope time-lapse incubator at
37C in 5.5% CO2, 5% O2 and 89.5% N2 for at least 5 days. Cul-
ture was temporarily interrupted on day 3 in order to
re-fresh the medium. This was performed by removing 20 ll
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with fresh, pre-equilibrated medium. The built-in micro-
scope was used to acquire images of each fertilized oocyte
every 20 min through seven focal planes.Trophectoderm biopsy and pre-implantation
genetic screening
Of the blastocysts in this study, 69 (70.41%) of them
underwent a series of three 4-lm diameter laser pulses
(Saturn Active laser and Integra micromanipulator;
Research Instruments) to breach the zona pellucida on
day 3 of culture in order to facilitate trophectoderm her-
niation for biopsy. For the remaining 29 (29.59%) blasto-
cysts, laser breaching was performed at the time of the
biopsy procedure. No differences were observed in time
from insemination to start of blastulation (tSB) or time
from insemination to formation of a full blastocyst (tB)
between embryos which underwent this procedure and
those which did not.
The timing of the procedure and the stage of blasto-
cyst development when trophectoderm biopsy was under-
taken varied in this study as they were performed in a
minimum number of cohorts to reduce disruption to the
incubation and for efficient working practice. All biopsies
were performed on blastocyst-stage embryos on day 5 or
6 post oocyte recovery. The minimum stage and quality
criteria for selection of blastocysts for biopsy and vitrifi-
cation in this study were embryos that were at least full
blastocysts, with at least a fair, easily discernible inner
cell mass and at least a few cells forming a loose troph-
ectoderm (equivalent to stage 2 grade 2; Alpha and
ESHRE, 2011a,b).
The time of hatching could not be reliably assessed in
the embryos where a facilitative breach was made in the
zona pellucida. Where observed, the time from insemina-
tion to start of blastulation was recorded for the first
expansion episode only and only when expansion occurred
prior to biopsy. The cycles of collapse and expansion,
although observed in some of the blastocysts, were not
recorded.
Up to three blastocysts per patient were biopsied in
one dish in individually labelled 20-ll microdrops of
G-MOPS buffered medium (Vitrolife, Sweden) using a
33–37-lm inner diameter blastomere biopsy micropipette
(Humagen, Origio). Where required, the zona pellucida
was breached using a series of 4-lm laser pulses and 5–10
trophoblast cells aspirated into the biopsy pipette. Stron-
ger laser pulses of up to 15 lm were used with aspiration
and mechanical pressure to remove the cells from the
blastocyst. In compliance with UK regulation and good
practice, witnessing was performed at every stage by
manual witnessing or Matcher barcode electronic witness-
ing (IMT International). Time-lapse monitoring ceased for
the particular blastocysts that were removed from the
EmbryoScope for biopsy. Following biopsy, the biopsied
cells were placed into 0.2 ml thin walled-tubes and sealed
and frozen by placing them into a freezer at 20C prior
to genetic screening and the blastocysts vitrified
(Kitazato; Hunter Scientific, UK).Trophectoderm biopsies of 98 blastocysts were ampli-
fied and analysed by either whole-genome amplification
and array comparative genomic hybridization (n = 37; Gen-
esis Genetics Europe, Nottingham, UK) or by single-nucle-
otide polymorphism microarray (n = 61; Natera, California,
USA). Embryos were categorized as ‘single’ or ‘multiple’
aneuploid depending on the number of chromosomes
affected.
The method by which analysis of trophectoderm
biopsies via single-nucleotide polymorphism microarray
occurred has previously been described (Johnson et al.,
2010a,b). Briefly, biopsies were lysed and heat inactivated
prior to DNA amplification. In order to determine the
source of aneuploidy, parental buccal swabs or blood sam-
ples were collected. Genomic DNA was isolated and the
standard Infinium II protocol (Illumina, San Diego, CA,
USA) was used for analysis of these samples. The geno-
type of the biopsy samples was determined using Infinium
II genotyping microarrays (CytoSNP-12 chips). Chromo-
some imbalances were determined using a specific algo-
rithm, described in Johnson et al. (2010b), which used
the information gained from the parental genotype and
the biopsy sample to determine both whole-chromosome
imbalances and structural abnormalities, along with the
parental source of the aberration.
The method by which analysis of trophectoderm biop-
sies via array comparative genomic hybridization occurred
as has previously been described (Fishel et al., 2011).
Briefly, DNA was amplified from the biopsied cells using
the SurePlex DNA Amplification System (BlueGnome, Cam-
bridge, UK) according to the manufacturer’s instructions.
Amplification was assessed by DNA gel electrophoresis
and only samples generating amplified product were
labelled. Test and control sample product and SureRef
Male DNA (BlueGnome) were labelled with Cy3 and Cy5,
respectively, using the BlueGnome fluorescent labelling
system, according to the manufacturer’s instructions.
Labelled test and control sample and SureRef Male DNA
were co-hybridized using 24Sure microarrays version 2
(BlueGnome). The resulting 24Sure microarrays were
hybridized, washed and scanned according to the manufac-
turer’s protocol. Scanned images were analysed and quan-
tified and whole-chromosomal copy number ratios were
reported using the Cytochip algorithm fixed settings in
BlueFuse Multi Software (BlueGnome).Evaluation of time-lapse images
Time-lapse images were collected for the duration of the
culture period, to the point of biopsy and were used for
the assessment of fertilization and embryo development.
The time of insemination by ICSI was programmed into
the EmbryoScope when the slide was loaded, as the time
point midway through the ICSI procedure. The Embryo-
Viewer image analysis software was used to log and dis-
play the precise timing of developmental events as they
were annotated by the embryologists studying the
time-lapse images. Table 1 outlines the definitions of
morphokinetic variables that were recorded in this study
of 2 pronuclei embryos up to the point of trophectoderm
(A) Start of blastulation (tSB)    
250µm
25µm
(B) Blastocyst (tB) 
Figure 1 Time-lapse images of the same embryo demonstrating its appearance at specific time points as utilized in this study. (A)
Human embryo at 106.8 hpi, with the start of a cavity forming (arrow), at tSB. (B) Human blastocyst at 112.1 hpi, with a blastocoele
filling the embryo with <10% increase in its diameter, at tB.
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tion (hpi). All annotations were made prior to the result
of the biopsy analysis and were therefore blind. Example
images show how the start and completion of blastulation
were identified (Figure 1).
Data analysis
Embryos with incomplete annotations, failed amplification
and/or abnormal or lack of fertilization were excluded from
analysis. The time variables were tested for normality using
Shapiro–Wilks test for normality. Since most variables were
foundnot tobenormallydistributed,non-parametric testswere
used to determine whether differences were significant. The
Mann–Whitney–Wilcoxon test was used to test differences in
morphokinetic variables, whilst Fisher’s test (odds ratio differ-
ent toone)wasused to test differences in incidence rateofmul-
tinuclearity and irregular cleavage patterns. The statistical
analyses were performed using R statistical software version
2.15.0 (R Foundation for Statistical Computing).
Algorithm using non-invasive morphokinetics to
categorize the risk of aneuploidy
Morphokinetic variables found to differ between euploid
and aneuploid embryos (single and multiple aneuploid
combined) were used to build a decision tree model by
recursive partitioning to partition the embryos into groups
depending on the value of the variables tSB and tB. The
recursive partitioning was optimized by the logWorth
value. The partitioning process stopped when all new
steps had a logWorth value below one (non-significant
splits). The model classified embryos into three classes
of aneuploidy risk: low, medium or high risk. The recur-
sive partitioning and the probability of a random embryo
in a particular risk class being aneuploid were calculated
in JMP version 10.0 (SAS Institute).Results
The time of initiation of compaction (tSC) was significantly
delayed (P = 0.02) for multiple aneuploid embryos (median
85.1 hpi, range 64.9–113.0 hpi) compared with euploid
embryos (median 79.7 hpi, range 56.3–107.6 hpi). The time
of initiation of blastulation (tSB) was significantly delayed
(P = 0.004 and 0.006) more than 6 h for both single aneuploid
embryos (median 103.4, range 79.8–121.5 hpi) and multiple
aneuploid embryos (median 101.9 hpi, range 86.8–129.4 hpi)
compared with euploid embryos (median 95.1 hpi, range
85.2–113.9 hpi). The time of full blastulation (tB) was signifi-
cantly delayed (P = 0.01) for 5 h formultiple aneuploid embryos
(median 110.9 hpi, range 90.1–137.0 hpi) compared with
euploid embryos (median 105.9, range 86.8–122.3 hpi). All
other timings testedwere not significantly different (Table 2).
No significant differences were observed between aneu-
ploid and euploid embryos in the length of the first or sec-
ond cell cycle, synchrony of the second or third cell cycle,
or the duration of blastulation (Table 3). No significant dif-
ferences were observed between aneuploid and euploid
embryos in multinucleation at the 2-cell stage or irregular
division patterns (direct or rapid division defined as <5 h)
cleavage from 1ﬁ 3 or from 2ﬁ 5 cells (Table 4).
Modelling
Since tSB and tB were found to differ significantly between
euploid and aneuploidy embryos, these variables were
selected for the simple classification model with three risk
classes of aneuploidy (Table 5 and Figure 2).
The following algorithm was derived using the recursive
partitioning method in R: low risk, tB <122.9 hpi and tSB
< 96.2 hpi; medium risk, tB < 122.9 hpi and tSB  96.2 hpi;
high risk, tB  122.9 hpi. When the data were divided into
the three different classes the area under the receiver
operating characteristic curve was 0.72.
Table 2 Timing of divisions for euploid, single aneuploid and multiple aneuploid embryos.
Euploid Single aneuploid Multiple aneuploid
25th
percentile
(hpi)
Median
(hpi)
75th
percentile
(hpi)
n 25th
percentile
(hpi)
Median
(hpi)
75th
percentile
(hpi)
n P-
value
25th
percentile
(hpi)
Median
(hpi)
75th
percentile
(hpi)
n P-
value
tPNfaded 20.8 23.2 25.2 32 21.2 23.1 24.8 26 NS 20.8 22.6 23.9 30 NS
t2 23.2 25.1 27.5 38 23.5 25.1 27.4 30 NS 23.3 24.9 26.9 30 0 NS
t3 31.1 35.0 38.3 38 33.4 36.9 39.2 30 NS 33.2 35.6 37.4 30 NS
t5 43.7 48.5 51.5 38 44.9 50.2 52.2 30 NS 43.9 47.7 50.6 30 NS
t8 52.6 56.1 63.1 35 51.2 56.2 60.1 27 NS 48.8 54.0 60.3 27 NS
tSC 74.1 79.7 85.4 35 75.3 80.7 86.7 30 NS 80.1 85.1 89.6 28 0.02
*
tM 79.6 83.5 87.8 32 80.5 87.9 93.6 29 NS 83.9 88.2 94.7 27 NS
tSB 91.7 95.1 101.5 38 96.4 103.4 110.2 30 0.004
* 97.0 101.9 107.3 30 0.006**
tB 101.2 105.9 111.3 38 102.6 109.2 116.0 30 NS 105.9 110.9 116.3 29 0.01
*
tEB 104.5 110.6 114.0 18 105.3 109.2 113.3 13 NS 107.5 115.3 124.9 9 NS
tHB 107.5 109.9 116.6 15 107.3 116.5 120.8 9 NS 114.5 115.4 118.4 6 NS
Mann–Whitney–Wilcoxon test, P-values of the two types of aneuploidy against the euploid: *P < 0.05; **P < 0.01.
hpi = hours post insemination; n = number of embryos: see Table 1 for other definitions.
Table 3 Times of of developmental periods for euploid, single aneuploid and multiple aneuploid embryos.
Euploid Single aneuploid Multiple aneuploid
25th percentile
(h)
Median
(h)
75th percentile
(h)
n 25th percentile
(h)
Median
(h)
75th percentile
(h)
n 25th percentile
(h)
Median
(h)
75th percentile
(h)
n
cc2 9.8 10.7 11.8 38 10.3 11.4 11.9 30 9.4 11.3 12.0 30
cc3 10.8 12.5 14.0 38 11.7 12.6 13.7 30 11.3 12.3 14.3 30
s2 0 1.0 4.0 38 0 0.5 1.5 30 0 1.0 4.0 30
s3 2.6 8.7 15.9 35 3.0 6.7 10.4 27 2.5 4.0 13.9 27
Blastulation 6.8 8.3 11.0 38 3.6 6.9 10.9 30 5.3 9.7 12.3 29
Mann–Whitney–Wilcoxon test, P-values of the two types of aneuploidy against the euploid: No statistically significant differences were found (P  0.05).
n = number of embryos; see Table 1 for other definitions.
482
A
C
am
p
b
e
ll
e
t
al.
Table 4 Incidence rates of multinuclearity and irregular division patterns for
euploid, single aneuploid and multiple aneuploid embryos.
Euploid Single aneuploid Multiple aneuploid
Incidence (%) n Incidence (%) n Incidence (%) n
MN2 13 38 16 30 10 30
MN4 0 38 0 30 0 30
1ﬁ 3 18 38 0 30 10 30
2ﬁ 5 2 38 3 30 13 30
Fisher’s test for significant differences between the two types of aneuploidy
against the euploid: no significant differences were found.
n = number of embryos; see Table 1 for other definitions.
Table 5 A time-lapse derived model for the classification of ploidy with
associated incidence rates and probabilities of aneuploidy.
Risk class Definition n Incidence Probability
Low tB <122.9 hpi and tSB <96.2 hpi 36 0.36 0.37
Medium tB <122.9 hpi and tSB 96.2 hpi 49 0.69 0.69
High tB 122.9 hpi 12 1.00 0.97
All 97 0.61 0.61
Corrected Akaike information criterion is 296; area under the receiver operating
characteristic curve is 0.72; imputes = 1.
hpi = hours post insemination; n = number of embryos; incidence = incidence rate
of aneuploidy embryos; probability = probability estimated using recursive par-
titioning-derived risk classification of an embryo being aneuploid; see Table 1 for
other definitions.
tB, (hpi)
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 (h
pi
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Figure 2 The three classes of aneuploidy risk (low, medium
and high) based on time from insemination to a full blastocoele
where the blastocyst has not yet started expansion (tB) and
time from insemination to start of blastulation (tSB). Area under
the receiver operating characteristic curve is 0.72. hpi = hours
post insemination.
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As far as is known, this is the first paper demonstrating an
association between human embryo ploidy and morphoki-
netics derived from time-lapse technology. The recent ret-
rospective study by Meseguer et al. (2012), which set out to
quantify the effect of using stable time-lapse cultureconditions and morphokinetic variables for embryo selec-
tion, used clinical pregnancy as the end point. This was
defined by the presence of gestational sacs with fetal heart-
beat during week 7 of gestation. However, it is likely that a
proportion of these early IVF pregnancies will be aneuploid.
Fragouli and Wells (2011) discussed the landscape of blasto-
cyst comprehensive cytogenetic analysis and reported over-
all aneuploidy rates in blastocysts to be greater than 50%.
They suggest that the majority of biological selection
against aneuploidy and genetic anomalies occurs at or after
the time of implantation. It is widely accepted that a major
cause of failed implantations or miscarriage following
embryo transfer is the (unknowing) transfer of aneuploid
embryos. Up until now, the only means available to IVF
centres for assessing ploidy in embryos has been polar body,
blastomere or trophoblast biopsy with PGS. Ploidy of the
embryos in this study was assessed by screening of the
trophectoderm to give full chromosome copy number,
which is considered to give high concordance with the inner
cell mass, but may still not be 100% accurate.
Alfarawati et al. (2011) previously compared blastocyst
qualitative morphology with ploidy and demonstrated only
a weak association between blastocyst morphology and
aneuploidy. They reported that, concerning the growth rate
of blastocysts, there was an insignificant trend toward aneu-
ploid embryos showing slower progression to the most
advanced blastocyst stages and that embryos with complex
aneuploidy were most delayed. This study was performed
without the benefit of time-lapse technology and the
484 A Campbell et al.findings were not clinically applicable as no clear cut-off
time point was given for discrimination between complex
aneuploid embryos and euploid ones. The time or frequency
of blastocyst morphological assessment was not discussed in
that paper.
From the cohort of blastocysts that underwent PGS in
this study, the overall incidence rate of aneuploidy was 61%.
The model used the morphokinetic variables tSB and tB of
these embryos of known ploidy to classify a blastocyst’s risk
of aneuploidy. The model can therefore be used to rank
individual and unscreened blastocysts as having low (proba-
bility 0.37), medium (probability 0.69) or high risk (probabil-
ity 0.97) of aneuploidy. Especially where there is a choice of
embryos available, the model could be useful in reducing
the chance of selecting an aneuploid embryo. The classifica-
tion from this model may, therefore, be used clinically to
rank embryos for transfer and could also be used alongside
PGS in order to prioritize embryos for biopsy and screening,
particularly where costs are based on the number of
embryos screened. Additional data may facilitate the fine
tuning of this algorithm.
Embryos with rapid cleavage from 2 to 3 cells in less than
5 h have been reported to have a significantly lower implan-
tation potential than embryos with a normal cell cycle
length (Rubio et al., 2012). The normal cell cycle time has
been established to be 10–12 h (Cummins et al., 1986)
and therefore there is sufficient time for DNA replication.
It is unknown if a causal relationship to ploidy exists in all
cases of such anomalous cleavage: whether rapid cleavage
provides insufficient time for complete genome replication
resulting in aneuploidy or whether a particular existing
aneuploidy results in erroneous cleavage patterning. For
example, some aneuploidies are lethal during the preim-
plantation stage, such as many monosomies, whilst some,
such as trisomies 13, 18 and 21, are compatible with
full-term delivery. Somfai et al. (2010) reported a high fre-
quency of chromosomal anomalies in bovine embryos which
developed from zygotes that exhibited direct division to
three from one cell, although rapid cleavage was observed
in a small proportion of both euploid (18%) and aneuploid
embryos (5% overall) in the present study. The incidence
of such rapid cleavage was not assessed in embryos with
arrested development in this study and further research into
such cleavage patterning, such as reverse cleavage, is
underway.
This study developed a model based on this study cen-
tre’s own culture systems, in which all controllable environ-
mental factors have been standardized and with a strict
annotation policy followed by laboratory staff. This gener-
ated two precise time points, the start of blastulation and
the time that the embryo reached the full blastocyst stage,
as important markers in this model for classifying the risk of
ploidy. With standard incubation, embryologists will be
unable to annotate these timings precisely without tremen-
dous disruption and compromise to incubation and working
practice. Whilst a daily observational procedure could be
applied on day 4 at around the same time of day as the
insemination occurred (96 hpi) and another on day 5 at a
similar time (120 hpi) in an attempt to align with the tempo-
ral values in this model, the facility to study and rewind
time-lapse images to identify the point of blastulation initi-
ation (tSB) and completion of blastulation (tB) is essential tothis modelling to permit a high degree of confidence in this
data. Furthermore, the accuracy of the model is dependent
on the 20-min imaging interval (i.e. capable of generating
19 images in 6 h) It is unknown at this time whether specific
time points from this model can be applied to a different
culture system, culture media, plastic ware, gas mix, air
purity, etc., even with time-lapse technology.
This model for categorizing the risk of aneuploidy using
non-invasive methods should improve clinical outcome.
Other systems that simply predict the occurrence of an
embryo to undergo blastulation (Wong et al., 2010) are
unlikely to be as clinically robust given that all aneuploid
pregnancies, miscarriages and live births, ipso facto, devel-
oped to and beyond the blastocyst stage, as did the many
aneuploid blastocysts that failed to become pregnancies.
The high incidence of aneuploidy in blastocysts (61% in this
study), confirms the clinical limitations of time-lapse sys-
tems used only to select embryos that are predicted to
become blastocysts.
The period leading up to blastulation is a period of
intense cellular metabolic activity, gene activation, rapidly
increasing cell division and differentiation. Cell division and
the mitotic process is a series of complex structural rear-
rangements involving the kinetochore attachments to the
microtubules (Gonen et al., 2012), cohesion molecules for
the crucially precise separation of the chromosome to
ensure correct alignment on the spindle (Clift and Marston,
2011), the spindle assembly complex and many highly spe-
cialized proteins subject to precise gene expression (Vogt
et al., 2008). Although the cause of a temporal delay in
aneuploid embryos compared with their euploid counter-
parts is not yet fully explained, there exist error detection
and repair systems within the cell to prevent aneuploidy
(Nasmyth and Haering, 2009). It is highly probable, there-
fore, that mitotic errors in individual cells at this stage of
the rapidly developing embryo involve complex biochemical
systems delaying karyo- and cytokinesis, which result in the
gross observation of delayed blastulation.
Time-lapse photography in a closed incubation system
such as the EmbryoScope, when used precisely to measure
the initiation and completion of blastulation, appears to be
the most reliable non-invasive method of ranking the risk of
aneuploidy in advanced-stage embryos. It is unlikely ever to
be as absolute as gaining accurate chromosome copy number
from biopsied cells, but it is an important tool to enhance the
chances of a live birth following IVF by non-invasive means.
Further studies are underway to quantify further morphoki-
netic variables, to observe the impact of specific aneuploidy
data and to prospectively test this model.
This study indicates that, with time-lapse monitoring of
embryo development to blastocyst in a closed incubation
system, it is possible, where there are alternative embryos
available within a cohort, to avoid the selection of embryos
having a high risk of aneuploidy and to preferentially select
embryos with a greatly reduced risk of aneuploidy based on
morphokinetic timing.
This non-invasive approach may be offered to patients as
an alternative to PGS or, indeed, as a complementary sys-
tem. This model for classifying the risk of aneuploidy
requires time-lapse technology to enable identification of
specific time points for embryo development up to the
blastocyst stage. This accessible and non-invasive embryo
Modelling a risk classification of aneuploidy in human embryos 485selection model may be used for patients electing against
invasive genetic screening technology or for clinics without
the skills or access to PGS.
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